Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $50,940 | 15 | 91.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,000 | 1 | 5.4% |
| Travel and Lodging | $1,007 | 3 | 1.8% |
| Food and Beverage | $494.77 | 10 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $32,198 | 12 | $0 (2024) |
| Allergan, Inc. | $7,030 | 4 | $0 (2020) |
| Acorda Therapeutics, Inc | $5,622 | 4 | $0 (2017) |
| Biohaven Pharmaceutical Holding Company Ltd. | $4,750 | 2 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $3,342 | 6 | $0 (2017) |
| Biohaven Pharmaceuticals, Inc. | $2,500 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,950 | 8 | ABBVIE INC. ($12,950) |
| 2023 | $19,192 | 2 | ABBVIE INC. ($19,192) |
| 2022 | $4,805 | 4 | Biohaven Pharmaceutical Holding Company Ltd. ($4,750) |
| 2021 | $2,500 | 1 | Biohaven Pharmaceuticals, Inc. ($2,500) |
| 2020 | $1,500 | 1 | Allergan, Inc. ($1,500) |
| 2019 | $5,530 | 3 | Allergan Inc. ($5,530) |
| 2017 | $8,964 | 10 | Acorda Therapeutics, Inc ($5,622) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| 11/22/2024 | ABBVIE INC. | QULIPTA (Drug) | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $50.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 11/12/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 10/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | UBRELVY (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| 12/13/2023 | ABBVIE INC. | UBRELVY (Drug) | Consulting Fee | Cash or cash equivalent | $18,750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2023 | ABBVIE INC. | UBRELVY (Drug) | Travel and Lodging | In-kind items and services | $441.90 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: PRIMARY CARE | ||||||
| 03/16/2022 | Biohaven Pharmaceutical Holding Company Ltd. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 11/16/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: PRIMARY CARE | ||||||
| 12/18/2020 | Allergan, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 11/04/2019 | Allergan Inc. | UBRELVY (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2019 | Allergan Inc. | — | Consulting Fee | Cash or cash equivalent | $4,240.00 | General |
| 08/30/2019 | Allergan Inc. | — | Travel and Lodging | In-kind items and services | $390.00 | General |
| 11/14/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: AED | ||||||
| 11/14/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Travel and Lodging | Cash or cash equivalent | $175.00 | General |
| Category: AED | ||||||
| 11/14/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $60.75 | General |
| Category: AED | ||||||
| 11/14/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $59.73 | General |
| Category: AED | ||||||
| 11/14/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $40.33 | General |
| Category: AED | ||||||
| 11/14/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $6.05 | General |
| Category: AED | ||||||
About Dr. Richard Lipton, M.D
Dr. Richard Lipton, M.D is a Specialist healthcare provider based in Danbury, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1982609327.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Lipton, M.D has received a total of $55,442 in payments from pharmaceutical and medical device companies, with $12,950 received in 2024. These payments were reported across 29 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($50,940).
Practice Information
- Specialty Specialist
- Location Danbury, CT
- Active Since 06/14/2005
- Last Updated 01/29/2013
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1982609327
Products in Payments
- UBRELVY (Drug) $22,598
- NURTEC ODT (Drug) $5,250
- TROKENDI XR (Drug) $3,342
- QULIPTA (Drug) $1,600
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Danbury
Dr. John Gelinas, M.d, M.D
Specialist — Payments: $359,149
Dr. David Kloth, Md, MD
Specialist — Payments: $213,581
Dr. Brian Pollack, M.d, M.D
Specialist — Payments: $31,732
Dr. Richard Lee, M.d, M.D
Specialist — Payments: $4,963
Dr. Dov Bloch, M.d, M.D
Specialist — Payments: $4,707
Purvi Shah, M.d, M.D
Specialist — Payments: $2,798